Insider Transactions in Q1 2024 at Fate Therapeutics Inc (FATE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2024
|
Edward J Dulac Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,447
-2.35%
|
$17,129
$7.77 P/Share
|
|
Jan 29
2024
|
Edward J Dulac Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,849
-1.75%
|
$9,245
$5.0 P/Share
|
|
Jan 09
2024
|
Edward J Dulac Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,028
-6.23%
|
$28,112
$4.37 P/Share
|
|
Jan 09
2024
|
J Scott Wolchko President and CEO |
SELL
Open market or private sale
|
Direct |
14,391
-3.73%
|
$57,564
$4.37 P/Share
|
|
Jan 09
2024
|
Bahram Valamehr Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
11,271
-6.66%
|
$45,084
$4.38 P/Share
|
|
Jan 09
2024
|
Cindy Tahl General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
10,874
-7.1%
|
$43,496
$4.37 P/Share
|
|
Jan 02
2024
|
Edward J Dulac Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,182
-4.39%
|
$15,546
$3.66 P/Share
|